Marilyn Pesci

835 total citations
10 papers, 587 citations indexed

About

Marilyn Pesci is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Marilyn Pesci has authored 10 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Marilyn Pesci's work include Inflammatory Bowel Disease (9 papers), Microscopic Colitis (5 papers) and Autoimmune and Inflammatory Disorders (3 papers). Marilyn Pesci is often cited by papers focused on Inflammatory Bowel Disease (9 papers), Microscopic Colitis (5 papers) and Autoimmune and Inflammatory Disorders (3 papers). Marilyn Pesci collaborates with scholars based in United States and Italy. Marilyn Pesci's co-authors include Leonard Baidoo, Kevin E. Kip, Wolfgang H. Schraut, Ewen M. Harrison, Antonia R. Sepulveda, Miguel Regueiro, Scott E. Plevy, Sandra El‐Hachem, David G. Binion and Miguel Regueiro and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Digestive Diseases and Sciences.

In The Last Decade

Marilyn Pesci

10 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilyn Pesci United States 5 556 502 230 35 33 10 587
Eric Froguel France 4 391 0.7× 331 0.7× 191 0.8× 39 1.1× 50 1.5× 6 444
Erzsébet Komáromi Hungary 7 547 1.0× 485 1.0× 267 1.2× 34 1.0× 25 0.8× 15 596
Lieven Vandeputte Belgium 5 320 0.6× 290 0.6× 100 0.4× 29 0.8× 27 0.8× 8 359
Lydia White United Kingdom 7 462 0.8× 423 0.8× 283 1.2× 34 1.0× 56 1.7× 8 607
J Bélaïche Belgium 8 296 0.5× 263 0.5× 136 0.6× 23 0.7× 42 1.3× 20 361
Gyoo Moon South Korea 4 399 0.7× 333 0.7× 224 1.0× 50 1.4× 31 0.9× 4 498
Elisabeth Evans United States 7 279 0.5× 267 0.5× 212 0.9× 41 1.2× 29 0.9× 12 391
Tommy Holmström Sweden 8 266 0.5× 257 0.5× 128 0.6× 13 0.4× 34 1.0× 11 331
Clotilde Baudry France 6 282 0.5× 238 0.5× 120 0.5× 62 1.8× 26 0.8× 9 335
Dupas Jl France 7 286 0.5× 246 0.5× 157 0.7× 50 1.4× 50 1.5× 38 387

Countries citing papers authored by Marilyn Pesci

Since Specialization
Citations

This map shows the geographic impact of Marilyn Pesci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn Pesci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn Pesci more than expected).

Fields of papers citing papers by Marilyn Pesci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn Pesci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn Pesci. The network helps show where Marilyn Pesci may publish in the future.

Co-authorship network of co-authors of Marilyn Pesci

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn Pesci. A scholar is included among the top collaborators of Marilyn Pesci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn Pesci. Marilyn Pesci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Regueiro, Miguel, Sandra El‐Hachem, Kevin E. Kip, et al.. (2011). Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn’s Disease. Digestive Diseases and Sciences. 56(12). 3610–3615. 33 indexed citations
2.
Regueiro, Miguel, Kevin E. Kip, Wolfgang H. Schraut, et al.. (2010). Crohnʼs disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflammatory Bowel Diseases. 17(1). 118–126. 114 indexed citations
3.
Regueiro, Miguel, Kevin E. Kip, Wolfgang H. Schraut, et al.. (2010). W1298 4.5 Yr Follow-up of Patients Enrolled in the Randomized Controlled Trial (RCT) of Infliximab (Inf) for Prevention of Postoperative Crohn's Disease (CD). Gastroenterology. 138(5). S–694. 15 indexed citations
4.
Regueiro, Miguel, Sandra El‐Hachem, Kevin E. Kip, et al.. (2010). M1225 Correlation of Histologic and Endoscopic Scores for Evaluation of Crohn's Disease Recurrence After Ileal Resection and Infliximab Therapy. Gastroenterology. 138(5). S–358. 4 indexed citations
5.
Schraut, Wolfgang H., Leonard Baidoo, Kevin E. Kip, et al.. (2009). T1207 Two Year Postoperative Follow-Up of Patients Enrolled in the Randomized Controlled Trial (RCT) of Infliximab (IFX) for Prevention of Recurrent Crohn's Disease (CD). Gastroenterology. 136(5). A–522. 10 indexed citations
6.
El‐Hachem, Sandra, Miguel Regueiro, Wolfgang H. Schraut, et al.. (2009). Long-term follow-up of patients enrolled in the Randomized Controlled Trial (RCT) of Infliximab for prevention of recurrent Crohnʼs Disease (CD). Inflammatory Bowel Diseases. 15. S11–S11. 1 indexed citations
7.
Kip, Kevin E., Wolfgang H. Schraut, Leonard Baidoo, et al.. (2009). Long-Term Follow-up of Patients Enrolled in the Randomized Controlled Trial (RCT) of Infliximab (INF) for Prevention of Postoperative Crohnʼs Disease (CD). The American Journal of Gastroenterology. 104. S459–S459. 1 indexed citations
8.
9.
Regueiro, Miguel, Wolfgang H. Schraut, Leonard Baidoo, et al.. (2008). Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection. Gastroenterology. 136(2). 441–450.e1. 404 indexed citations
10.
Pesci, Marilyn, et al.. (1992). [Comparative study of the effects of famotidine and omeprazole in the prevention of the aspiration of gastric contents syndrome in elective surgery].. PubMed. 58(4). 207–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026